Dovrolis N - Search Results

1

Co-expression of fibrotic genes in inflammatory bowel disease; A localized event?

Dovrolis N, Filidou E, Tarapatzi G, Kokkotis G, Spathakis M, Kandilogiannakis L, Drygiannakis I, Valatas V, Arvanitidis K, Karakasiliotis I, Vradelis S, Manolopoulos VG, Paspaliaris V, Bamias G, Kolios G. Dovrolis N, et al. Front Immunol. 2022 Dec 23;13:1058237. doi: 10.3389/fimmu.2022.1058237. eCollection 2022. Front Immunol. 2022. PMID: 36632136 Free PMC article.

2

PepServe: a web server for peptide analysis, clustering and visualization.

Alexandridou A, Dovrolis N, Tsangaris GT, Nikita K, Spyrou G. Alexandridou A, et al. Among authors: dovrolis n. Nucleic Acids Res. 2011 Jul;39(Web Server issue):W381-4. doi: 10.1093/nar/gkr318. Epub 2011 May 13. Nucleic Acids Res. 2011. PMID: 21572105 Free PMC article.

3

Laying in silico pipelines for drug repositioning: a paradigm in ensemble analysis for neurodegenerative diseases.

Dovrolis N, Kolios G, Spyrou G, Maroulakou I. Dovrolis N, et al. Drug Discov Today. 2017 May;22(5):805-813. doi: 10.1016/j.drudis.2017.03.009. Epub 2017 Mar 29. Drug Discov Today. 2017. PMID: 28363518 Review.

4

Computational profiling of the gut-brain axis: microflora dysbiosis insights to neurological disorders.

Dovrolis N, Kolios G, Spyrou GM, Maroulakou I. Dovrolis N, et al. Brief Bioinform. 2019 May 21;20(3):825-841. doi: 10.1093/bib/bbx154. Brief Bioinform. 2019. PMID: 29186317 Review.

5

Gut Microbial Signatures Underline Complicated Crohn's Disease but Vary Between Cohorts; An In Silico Approach.

Dovrolis N, Drygiannakis I, Filidou E, Kandilogiannakis L, Arvanitidis K, Tentes I, Kolios G, Valatas V. Dovrolis N, et al. Inflamm Bowel Dis. 2019 Jan 10;25(2):217-225. doi: 10.1093/ibd/izy328. Inflamm Bowel Dis. 2019. PMID: 30346536

6

Systems biology in inflammatory bowel diseases: on the way to precision medicine.

Dovrolis N, Filidou E, Kolios G. Dovrolis N, et al. Ann Gastroenterol. 2019 May-Jun;32(3):233-246. doi: 10.20524/aog.2019.0373. Epub 2019 Apr 3. Ann Gastroenterol. 2019. PMID: 31040620 Free PMC article. Review.

7

Differential genetic and functional background in inflammatory bowel disease phenotypes of a Greek population: a systems bioinformatics approach.

Gazouli M, Dovrolis N, Franke A, Spyrou GM, Sechi LA, Kolios G. Gazouli M, et al. Among authors: dovrolis n. Gut Pathog. 2019 Jun 15;11:31. doi: 10.1186/s13099-019-0312-y. eCollection 2019. Gut Pathog. 2019. PMID: 31249629 Free PMC article.

8

The Interplay between Mucosal Microbiota Composition and Host Gene-Expression is Linked with Infliximab Response in Inflammatory Bowel Diseases.

Dovrolis N, Michalopoulos G, Theodoropoulos GE, Arvanitidis K, Kolios G, Sechi LA, Eliopoulos AG, Gazouli M. Dovrolis N, et al. Microorganisms. 2020 Mar 20;8(3):438. doi: 10.3390/microorganisms8030438. Microorganisms. 2020. PMID: 32244928 Free PMC article.

9

Type I and II Interferon Signatures Can Predict the Response to Anti-TNF Agents in Inflammatory Bowel Disease Patients: Involvement of the Microbiota.

Mavragani CP, Nezos A, Dovrolis N, Andreou NP, Legaki E, Sechi LA, Bamias G, Gazouli M. Mavragani CP, et al. Among authors: dovrolis n. Inflamm Bowel Dis. 2020 Sep 18;26(10):1543-1553. doi: 10.1093/ibd/izaa216. Inflamm Bowel Dis. 2020. PMID: 32812029

10

A main event and multiple introductions of SARS-CoV-2 initiated the COVID-19 epidemic in Greece.

Spanakis N, Kassela K, Dovrolis N, Bampali M, Gatzidou E, Kafasi A, Froukala E, Stavropoulou A, Lilakos K, Veletza S, Tsiodras S, Tsakris A, Karakasiliotis I. Spanakis N, et al. Among authors: dovrolis n. J Med Virol. 2021 May;93(5):2899-2907. doi: 10.1002/jmv.26778. Epub 2021 Feb 23. J Med Virol. 2021. PMID: 33410223

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

36 results

Search Page